BioMall
Brand Store/BDB Bioscience/BD PharmingenTM Purified Mouse Anti-Human IFN-gamma
BD PharmingenTM Purified Mouse Anti-Human IFN-gamma
GENERAL CATALOGUE

BD PharmingenTM Purified Mouse Anti-Human IFN-gamma

554699 ·

BDB Bioscience · Cat: 554699

Reach 3+ verified distributors

Catalog No: 554699
Category: reagents
Brand: BDB Bioscience

Description

Expression of IFN-gamma by stimulated human peripheral blood mononuclear cells PBMC . Human PBMC were stimulated for 6 hours with PMA 50 ng/ml; Sigma, Cat. No. P-8139 and calcium ionophore A23187 250 ng/ml; Sigma, Cat. No. C-9275 in the presence of GolgiStop Cat. No. 554724 . The PBMC were stained with PE-Cy5 Mouse Anti-Human CD3 Cat. No. 555334/561007 , fixed and permeabilized with BD Cytofix/Cytoperm Plus Kit with BD GolgiStop Cat. No. 554715 , and subsequently stained with 0.25 mug of PE Mouse Anti-Human IFN-gamma Cat. No. 554701/559327 . To demonstrate staining specificity, PE Mouse Anti-Human IFN-gamma antibody binding was blocked by preincubation of fixed/permeabilized cells with excess Purified Mouse Anti-Human IFN-gamma 5 mug; Cat. No. 554699/550011; right panel prior to staining. The quadrant markers for the bivariate dot plot were set based on autofluorescence controls and verified using the unlabeled antibody blocking control. Expression of IFN-gamma by stimulated human peripheral blood mononuclear cells PBMC . Human PBMC were stimulated for 6 hours with PMA 50 ng/ml; Sigma, Cat. No. P-8139 and calcium ionophore A23187 250 ng/ml; Sigma, Cat. No. C-9275 in the presence of GolgiStop Cat. No. 554724 . The PBMC were stained with PE-Cy5 Mouse Anti-Human CD3 Cat. No. 555334/561007 , fixed and permeabilized with BD Cytofix/Cytoperm Plus Kit with BD GolgiStop Cat. No. 554715 , and subsequently stained with 0.25 mug of PE Mouse Anti-Human IFN-gamma Cat. No. 554701/559327 . To demonstrate staining specificity, PE Mouse Anti-Human IFN-gamma antibody binding was blocked by preincubation of fixed/permeabilized cells with excess Purified Mouse Anti-Human IFN-gamma 5 mug; Cat. No. 554699/550011; right panel prior to staining. The quadrant markers for the bivariate dot plot were set based on autofluorescence controls and verified using the unlabeled antibody blocking control. Expression of IFN-gamma by stimulated human peripheral blood mononuclear cells PBMC . Human PBMC were stimulated for 6 hours with PMA 50 ng/ml; Sigma, Cat. No. P-8139 and calcium ionophore A23187 250 ng/ml; Sigma, Cat. No. C-9275 in the presence of GolgiStop Cat. No. 554724 . The PBMC were stained with PE-Cy5 Mouse Anti-Human CD3 Cat. No. 555334/561007 , fixed and permeabilized with BD Cytofix/Cytoperm Plus Kit with BD GolgiStop Cat. No. 554715 , and subsequently stained with 0.25 mug of PE Mouse Anti-Human IFN-gamma Cat. No. 554701/559327 . To demonstrate staining specificity, PE Mouse Anti-Human IFN-gamma antibody binding was blocked by preincubation of fixed/permeabilized cells with excess Purified Mouse Anti-Human IFN-gamma 5 mug; Cat. No. 554699/550011; right panel prior to staining. The quadrant markers for the bivariate dot plot were set based on autofluorescence controls and verified using the unlabeled antibody blocking control. Show More Expression of IFN-gamma by stimulated human peripheral blood mononuclear cells PBMC . Human PBMC were stimulated for 6 hours with PMA 50 ng/ml; Sigma, Cat. No. P-8139 and calcium ionophore A23187 250 ng/ml; Sigma, Cat. No. C-9275 in the presence of GolgiStop Cat. No. 554724 . The PBMC were stained with PE-Cy5 Mouse Anti-Human CD3 Cat. No. 555334/561007 , fixed and permeabilized with BD Cytofix/Cytoperm Plus Kit with BD GolgiStop Cat. No. 554715 , and subsequently stained with 0.25 mug of PE Mouse Anti-Human IFN-gamma Cat. No. 554701/559327 . To demonstrate staining specificity, PE Mouse Anti-Human IFN-gamma antibody binding was blocked by preincubation of fixed/permeabilized cells with excess Purified Mouse Anti-Human IFN-gamma 5 mug; Cat. No. 554699/550011; right panel prior to staining. The quadrant markers for the bivariate dot plot were set based on autofluorescence controls and verified using the unlabeled antibody blocking control. Show More Expression of IFN-gamma by stimulated human peripheral blood mononuclear cells PBMC . Human PBMC were stimulated for 6 hours with PMA 50 ng/ml; Sigma, Cat. No. P-8139 and calcium ionophore A23187 250 ng/ml; Sigma, Cat. No. C-9275 in the presence of GolgiStop Cat. No. 554724 . The PBMC were stained with PE-Cy5 Mouse Anti-Human CD3 Cat. No. 555334/561007 , fixed and permeabilized with BD Cytofix/Cytoperm Plus Kit with BD GolgiStop Cat. No. 554715 , and subsequently stained with 0.25 mug of PE Mouse Anti-Human IFN-gamma Cat. No. 554701/559327 . To demonstrate staining specificity, PE Mouse Anti-Human IFN-gamma antibody binding was blocked by preincubation of fixed/permeabilized cells with excess Purified Mouse Anti-Human IFN-gamma 5 mug; Cat. No. 554699/550011; right panel prior to staining. The quadrant markers for the bivariate dot plot were set based on autofluorescence controls and verified using the unlabeled antibody blocking control. Expression of IFN-gamma by stimulated human peripheral blood mononuclear cells PBMC . Human PBMC were stimulated for 6 hours with PMA 50 ng/ml; Sigma, Cat. No. P-8139 and calcium ionophore A23187 250 ng/ml; Sigma, Cat. No. C-9275 in the presence of GolgiStop Cat. No. 554724 . The PBMC were stained with PE-Cy5 Mouse Anti-Human CD3 Cat. No. 555334/561007 , fixed and permeabilized with BD Cytofix/Cytoperm Plus Kit with BD GolgiStop Cat. No. 554715 , and subsequently stained with 0.25 mug of PE Mouse Anti-Human IFN-gamma Cat. No. 554701/559327 . To demonstrate staining specificity, PE Mouse Anti-Human IFN-gamma antibody binding was blocked by preincubation of fixed/permeabilized cells with excess Purified Mouse Anti-Human IFN-gamma 5 mug; Cat. No. 554699/550011; right panel prior to staining. The quadrant markers for the bivariate dot plot were set based on autofluorescence controls and verified using the unlabeled antibody blocking control.

More from BDB Bioscience